Edwards Lifesciences Cost of Goods Sold 2010-2024 | EW

Edwards Lifesciences annual/quarterly cost of goods sold history and growth rate from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
  • Edwards Lifesciences cost of goods sold for the quarter ending September 30, 2024 was $0.263B, a 4.91% increase year-over-year.
  • Edwards Lifesciences cost of goods sold for the twelve months ending September 30, 2024 was $1.477B, a 34.86% increase year-over-year.
  • Edwards Lifesciences annual cost of goods sold for 2023 was $1.38B, a 27.71% increase from 2022.
  • Edwards Lifesciences annual cost of goods sold for 2022 was $1.08B, a 13.49% decline from 2021.
  • Edwards Lifesciences annual cost of goods sold for 2021 was $1.249B, a 15.57% increase from 2020.
Edwards Lifesciences Annual Cost of Goods Sold
(Millions of US $)
2023 $1,380
2022 $1,080
2021 $1,249
2020 $1,081
2019 $1,114
2018 $939
2017 $875
2016 $797
2015 $617
2014 $626
2013 $517
2012 $491
2011 $490
2010 $408
2009 $399
Edwards Lifesciences Quarterly Cost of Goods Sold
(Millions of US $)
2024-09-30 $263
2024-06-30 $285
2024-03-31 $386
2023-12-31 $543
2023-09-30 $251
2023-06-30 $257
2023-03-31 $330
2022-12-31 $258
2022-09-30 $254
2022-06-30 $269
2022-03-31 $299
2021-12-31 $310
2021-09-30 $312
2021-06-30 $334
2021-03-31 $293
2020-12-31 $296
2020-09-30 $281
2020-06-30 $238
2020-03-31 $265
2019-12-31 $286
2019-09-30 $292
2019-06-30 $304
2019-03-31 $232
2018-12-31 $235
2018-09-30 $225
2018-06-30 $246
2018-03-31 $234
2017-12-31 $235
2017-09-30 $213
2017-06-30 $211
2017-03-31 $216
2016-12-31 $213
2016-09-30 $201
2016-06-30 $203
2016-03-31 $180
2015-12-31 $176
2015-09-30 $147
2015-06-30 $159
2015-03-31 $136
2014-12-31 $160
2014-09-30 $168
2014-06-30 $151
2014-03-31 $146
2013-12-31 $144
2013-09-30 $128
2013-06-30 $124
2013-03-31 $121
2012-12-31 $122
2012-09-30 $112
2012-06-30 $130
2012-03-31 $127
2011-12-31 $120
2011-09-30 $126
2011-06-30 $128
2011-03-31 $117
2010-12-31 $114
2010-09-30 $96
2010-06-30 $100
2010-03-31 $99
2009-12-31 $102
2009-09-30 $99
2009-06-30 $102
2009-03-31 $97
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $39.062B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $211.041B 25.75
Intuitive Surgical (ISRG) United States $191.072B 99.90
Alcon (ALC) Switzerland $45.679B 32.16
IQVIA Holdings (IQV) United States $39.790B 21.92
IDEXX Laboratories (IDXX) United States $35.479B 41.78
DexCom (DXCM) United States $27.326B 41.15
Waters (WAT) United States $22.831B 33.76
SONOVA HOLDING (SONVY) Switzerland $22.110B 0.00
STERIS (STE) Ireland $21.616B 24.91
Hologic (HOLX) United States $18.294B 19.30
Sysmex ADR (SSMXY) Japan $12.864B 40.34
Fresenius Medical Care AG KGaA (FMS) Germany $12.499B 12.83
Globus Medical (GMED) United States $10.952B 27.89
Teleflex (TFX) United States $9.082B 14.49
Penumbra (PEN) United States $9.075B 88.89
Masimo (MASI) United States $8.696B 42.08
Glaukos (GKOS) United States $7.816B 0.00
PROCEPT BioRobotics (PRCT) United States $5.170B 0.00
Integer Holdings (ITGR) United States $4.587B 26.00
Inari Medical (NARI) United States $3.009B 0.00
TransMedics (TMDX) United States $2.886B 91.47
LivaNova (LIVN) United Kingdom $2.804B 16.18
Veracyte (VCYT) United States $2.802B 84.84
Nihon Kohden (NHNKY) Japan $2.648B 20.12
Elekta AB (EKTAY) Sweden $2.286B 18.62
Tandem Diabetes Care (TNDM) United States $2.010B 0.00
Integra LifeSciences Holdings (IART) United States $1.912B 9.99
RxSight (RXST) United States $1.776B 0.00
Alphatec Holdings (ATEC) United States $1.333B 0.00
Pulse Biosciences (PLSE) United States $1.222B 0.00
Artivion (AORT) United States $1.203B 79.75
OPKO Health (OPK) United States $1.060B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.938B 15.95
ORTHOFIX MEDICAL INC (OFIX) United States $0.741B 0.00
IRadimed (IRMD) United States $0.716B 38.68
Mesa Laboratories (MLAB) United States $0.643B 15.22
SiBone (SIBN) United States $0.639B 0.00
Pacific Biosciences Of California (PACB) United States $0.627B 0.00
OrthoPediatrics (KIDS) United States $0.623B 0.00
Paragon 28 (FNA) United States $0.597B 0.00
AxoGen (AXGN) United States $0.555B 0.00
Treace Medical Concepts (TMCI) United States $0.501B 0.00
CVRx (CVRX) United States $0.377B 0.00
Tactile Systems Technology (TCMD) United States $0.360B 19.51
ClearPoint Neuro (CLPT) United States $0.321B 0.00
Delcath Systems (DCTH) United States $0.307B 0.00
AngioDynamics (ANGO) United States $0.293B 0.00
Semler Scientific (SMLR) United States $0.289B 19.43
Inogen (INGN) United States $0.263B 0.00
NeuroPace (NPCE) United States $0.219B 0.00
Accuray (ARAY) United States $0.216B 0.00
Sight Sciences (SGHT) United States $0.213B 0.00
Nevro (NVRO) United States $0.189B 0.00
Atossa Genetics (ATOS) United States $0.189B 0.00
Alpha Tau Medical (DRTS) Israel $0.158B 0.00
KORU Medical Systems (KRMD) United States $0.132B 0.00
908 Devices (MASS) United States $0.124B 0.00
Spectral Diagnostics (EDTXF) Canada $0.116B 0.00
Sensus Healthcare (SRTS) United States $0.111B 16.51
EDAP TMS S.A (EDAP) France $0.095B 0.00
LENSAR (LNSR) United States $0.086B 0.00
WORK Medical Technology Group (WOK) China $0.082B 0.00
Monogram Orthopaedics (MGRM) United States $0.077B 0.00
Covalon Technologies (CVALF) Canada $0.071B 0.00
Hyperfine (HYPR) United States $0.069B 0.00
EnVVeno Medical (NVNO) United States $0.062B 0.00
InspireMD (NSPR) Israel $0.057B 0.00
Lucid Diagnostics (LUCD) United States $0.056B 0.00
Rapid Micro Biosystems (RPID) United States $0.054B 0.00
Vicarious Surgical (RBOT) United States $0.050B 0.00
Accelerate Diagnostics (AXDX) United States $0.043B 0.00
Envoy Medical (COCH) United States $0.041B 0.00
Neuronetics (STIM) United States $0.035B 0.00
Adagio Medical Holdings (ADGM) United States $0.034B 0.00
Biosig Technologies (BSGM) United States $0.033B 0.00
Precision Optics (POCI) United States $0.032B 0.00
DarioHealth (DRIO) United States $0.029B 0.00
Spectral AI (MDAI) United States $0.025B 0.00
NexGel (NXGL) United States $0.020B 0.00
Baird Medical Investment Holdings (BDMD) $0.020B 0.00
Ekso Bionics Holdings (EKSO) United States $0.019B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Aspira Women's Health (AWH) United States $0.014B 0.00
Autonomix Medical (AMIX) United States $0.013B 0.00
PAVmed (PAVM) United States $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.011B 0.00
T2 Biosystems (TTOO) United States $0.010B 0.00
Pixie Dust Technologies (PXDT) Japan $0.007B 0.00
Check-Cap (CHEK) Israel $0.006B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00